Termination of Lock-Up Term. Section 3.1 hereof shall terminate and have no further force or effect upon the earliest to occur of: (a) the date that is the later of (i) the third anniversary of the Closing Date and (ii) the date of the Second Pivotal Clinical Trial Readout; (b) the beneficial ownership of the Standstill Parties falls below three percent (3%) of the Shares of Then-Outstanding Common Stock; (c) a Change of Control of the Company; (d) a liquidation or dissolution of the Company; and ActiveUS 170815904v.19 (e) the date on which the Common Stock ceases to be registered pursuant to Section 12 of the Exchange Act.
Appears in 1 contract
Termination of Lock-Up Term. Section 3.1 hereof shall terminate and have no further force or effect upon the earliest to occur of:
(a) the date that is the later of (i) the third anniversary of the Closing Date and (ii) the date of the Second Pivotal Clinical Trial ReadoutDate;
(b) the beneficial ownership of the Standstill Parties falls below three percent (3%) of the Shares of Then-Outstanding Common Stock;
(c) a Change of Control of the Company;
(d) a liquidation or dissolution of the Company; and ActiveUS 170815904v.19and
(e) the date on which the Common Stock ceases to be registered pursuant to Section 12 of the Exchange Act.
Appears in 1 contract
Termination of Lock-Up Term. Section 3.1 hereof shall terminate and have no further force or effect upon the earliest to occur of:
: (a) the date that is the later of (i) the third anniversary of the Closing Date and (ii) the date of the Second Pivotal Clinical Trial Readout;
Date; (b) the beneficial ownership of the Standstill Parties falls below three percent (3%) of the Shares of Then-Outstanding Common Stock;
; (c) a Change of Control of the Company;
; (d) a liquidation or dissolution of the Company; and ActiveUS 170815904v.19
(e) the date on which the Common Stock ceases to be registered pursuant to Section 12 of the Exchange Act.. 6.3
Appears in 1 contract
Termination of Lock-Up Term. Section 3.1 hereof shall terminate and have no further force or effect upon the earliest to occur of:
(a) the date that is the later of (i) the third anniversary of the Closing Date and (ii) the date of the Second Pivotal Clinical Trial Readout;
(b) the beneficial ownership of the Standstill Parties falls below three percent (3%) of the Shares of Then-Outstanding Common Stock;
(c) a Change of Control of the Company;
(d) a liquidation or dissolution of the Company; and ActiveUS 170815904v.19and
(e) the date on which the Common Stock ceases to be registered pursuant to Section 12 of the Exchange Act.
Appears in 1 contract